A detailed history of Dt Investment Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Dt Investment Partners, LLC holds 260 shares of AZN stock, worth $19,557. This represents 0.0% of its overall portfolio holdings.

Number of Shares
260
Holding current value
$19,557
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$76.67 - $87.62 $19,934 - $22,781
260 New
260 $20,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $233B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Dt Investment Partners, LLC Portfolio

Follow Dt Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dt Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dt Investment Partners, LLC with notifications on news.